GCH1 and hereditary disease: Consistent with previous reports showing beneficial effects on pain relief in patients with GCH1 genetic disorders, our findings strongly suggest that GCH1 modulation can be effectively developed as a clinically applicable gene therapy strategy to treat neuropathic pain.